BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 15981014)

  • 1. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
    Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
    Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
    Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
    Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice.
    Tanji K; Mori F; Mimura J; Itoh K; Kakita A; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2010 Aug; 120(2):145-54. PubMed ID: 20339856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
    Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
    Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia with Lewy bodies in an elderly Greek male due to alpha-synuclein gene mutation.
    Morfis L; Cordato DJ
    J Clin Neurosci; 2006 Nov; 13(9):942-4. PubMed ID: 17049244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lewy bodies, a misleading marker for Parkinson's disease?].
    Duyckaerts C; Hauw JJ
    Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
    Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia with Lewy bodies.
    Verny M; Duyckaerts C
    Ann Med Interne (Paris); 1998 Jun; 149(4):209-15. PubMed ID: 11490548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies].
    Mizutani T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1262-3. PubMed ID: 10791093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease.
    Ishikawa A; Piao YS; Miyashita A; Kuwano R; Onodera O; Ohtake H; Suzuki M; Nishizawa M; Takahashi H
    Ann Neurol; 2005 Mar; 57(3):429-34. PubMed ID: 15732120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An atypical autopsy case of Lewy body disease with clinically diagnosed major depression: a clinical, radiological and pathological study.
    Iritani S; Tsuchiya K; Arai T; Akiyama H; Ikeda K
    Neuropathology; 2008 Dec; 28(6):652-9. PubMed ID: 18410279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial involvement in diffuse Lewy body disease.
    Terada S; Ishizu H; Yokota O; Tsuchiya K; Nakashima H; Ishihara T; Fujita D; Uéda K; Ikeda K; Kuroda S
    Acta Neuropathol; 2003 Feb; 105(2):163-9. PubMed ID: 12536227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.
    Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.